| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $148.2M | +61.1% |
| SG&A Expense | $42.5M | +5.7% |
| Operating Income | -$191.1M | -232.1% |
| Pre-tax Income | -$169.2M | -211.8% |
| Income Tax | -$14.1M | -133.5% |
| Net Income | -$153.2M | -237.7% |
| EPS (Basic) | -$3.69 | -250.0% |
| EPS (Diluted) | -$3.69 | -255.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98.4M | -37.0% |
| Short-term Investments | $368.6M | +18.5% |
| Current Assets | $480.2M | +1.2% |
| Total Assets | $484.2M | -13.7% |
| Current Liabilities | $28.1M | +25.1% |
| Total Liabilities | $30.3M | +16.1% |
| Stockholders' Equity | $453.7M | -15.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$134.3M | -6.0% |
| Capital Expenditures | $208K | -81.6% |
| Investing Cash Flow | $35.8M | -85.6% |
| Financing Cash Flow | $40.8M | +257.1% |
| Free Cash Flow | -$134.5M | -5.2% |